"Designing Growth Strategies is in our DNA"
To get information on various segments, share your queries with us
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2021-2034 |
|
Base Year |
2025 |
|
Estimated Year |
2026 |
|
Forecast Period |
2026-2034 |
|
Historical Period |
2021-2024 |
|
Growth Rate |
CAGR of 3.0% from 2026-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Procedure Type, Surgical Approach, Cancer Type, Provider, and Region |
|
By Procedure Type |
· Lobectomy · Segmentectomy · Pneumonectomy · Others |
|
By Surgical Approach |
· Open Surgery · Video-Assisted Thoracoscopic Surgery (VATS) · Robotic-Assisted Thoracic Surgery (RATS) |
|
By Cancer Type |
· Non–Small Cell Lung Cancer (NSCLC) · Small Cell Lung Cancer (SCLC) |
|
By Provider |
· Hospitals · Cancer Care Centers · Others |
|
By Region |
· North America (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country) o U.S. (By Cancer Type) o Canada (By Cancer Type) · Europe (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region) o U.K. (By Cancer Type) o Germany (By Cancer Type) o France (By Cancer Type) o Italy (By Cancer Type) o Spain (By Cancer Type) o Scandinavia (By Cancer Type) o Rest of Europe (By Cancer Type) · Asia Pacific (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region) o China (By Cancer Type) o Japan (By Cancer Type) o India (By Cancer Type) o Australia (By Cancer Type) o Southeast Asia (By Cancer Type) o Rest of Asia Pacific (By Cancer Type) · Latin America (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region) o Brazil (By Cancer Type) o Mexico (By Cancer Type) o Rest of Latin America (By Cancer Type) · Middle East & Africa (By Procedure Type, By Surgical Approach, By Cancer Type, By Provider, and by Country/Sub-region) o GCC (By Cancer Type) o South Africa (By Cancer Type) o Rest of the Middle East & Africa (By Cancer Type) |
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )